Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Sales | 7,421 | 6,048 | 5,578 | 5,878 | 2,776 |
| Cost of Goods | 6,180 | 4,989 | 4,648 | 5,251 | 2,586 |
| Gross Profit | 1,241 | 1,059 | 930 | 627 | 190 |
| Operating Expenses | 21,356 | 22,045 | 22,185 | 22,572 | 23,355 |
| Operating Income | -19,935 | -19,997 | -20,607 | -21,694 | -22,579 |
| Interest Expense | 686 | 673 | 426 | 137 | 68 |
| Other Income | 134 | 199 | -71 | 162 | -82 |
| Pre-tax Income | -20,487 | -20,471 | -21,104 | -21,669 | -22,729 |
| Net Income Continuous | -20,487 | -20,471 | -21,104 | -21,669 | -22,729 |
| Net Income | $-20,487 | $-20,471 | $-21,104 | $-21,669 | $-22,729 |
| EPS Basic Total Ops | -0.31 | -0.33 | -0.37 | -0.38 | -0.41 |
| EPS Basic Continuous Ops | -0.31 | -0.33 | -0.37 | -0.38 | -0.41 |
| EPS Diluted Total Ops | -0.31 | -0.33 | -0.37 | -0.38 | -0.41 |
| EPS Diluted Continuous Ops | -0.31 | -0.33 | -0.37 | -0.38 | -0.41 |
| EBITDA(a) | $-18,424 | $-18,434 | $-19,025 | $-20,086 | $-20,891 |